ArticleAntimicrobial agents and chemotherapy2004

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

Koen Andries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.